Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (17)

2024

  1. Estudio de estabilidad fisicoquímica y microbiológica de dos nuevos colirios de metilprednisolona sin conservantes

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 48, Núm. 4, pp. 145-152

  2. Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?

    Blood Advances

  3. Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops

    Farmacia Hospitalaria

  4. The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

    Pediatric Drugs, Vol. 26, Núm. 3, pp. 331-346

2023

  1. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

2021

  1. Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain

    Critical Care, Vol. 25, Núm. 1

  2. The importance of being able to compare: Methodologies that result in the best decisions

    Farmacia Hospitalaria

2019

  1. Long-term engraftment of human cardiomyocytes combined with biodegradable microparticles induces heart repair

    Journal of Pharmacology and Experimental Therapeutics, Vol. 370, Núm. 3, pp. 761-771

2018

  1. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

    Clinical and Translational Oncology, Vol. 20, Núm. 4, pp. 443-447

  2. Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer

    Revista Espanola de Patologia

2017

  1. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: A position statement of SEOM, SEAP and SEFH

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 688-691

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2010

  1. Drug delivery systems for potential treatment of intracellular bacterial infections

    Frontiers in Bioscience, Vol. 15, Núm. 2, pp. 397-417

2009

  1. Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 11, pp. 4816-4824

2006

  1. Estudio multicéntrico de prevalencia de hiperglucemia en pacientes hospitalizados con nutrición parenteral

    Farmacia Hospitalaria, Vol. 30, Núm. 1, pp. 12-19

  2. Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice

    Neurobiology of Aging, Vol. 27, Núm. 6, pp. 848-856